DNA methylation as a universal biomarker.
Cell-free circulating DNA carries not only tumor-specific changes in its sequence but also distinctive epigenetic marks, namely DNA methylation, in certain GC-rich fragments. These fragments are usually located within the promoters and first exons of many genes, comprising CpG islands. Analysis of DNA methylation using cell-free circulating DNA can facilitate development of very accurate biomarkers for detection, diagnosis, prediction of response to therapy and prognosis of outcomes. Recent data suggest that benign and inflammatory diseases have very specific methylation patterns within cell-free circulating DNA, which are different from the pattern of a malignant tumor of the same organ. In addition, specific methylation patterns have been detected for cancers of different organs, so a differential diagnosis of site-specific cancer appears feasible. Currently, cancer-related applications dominate the field, although methylation-based biomarkers may also be possible for other diseases, including neurodegenerative and psychiatric disorders.
Levenson
Victor V
VV
Department of Radiation Oncology, Rush University Medical Center, Chicago, IL 60612, USA. vlev.rush@gmail.com
D015415:Biomarkers / Q000378:metabolism*; D004247:DNA / Q000235:genetics / Q000378:metabolism*; D019175:DNA Methylation; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D011379:Prognosis; D016896:Treatment Outcome
D015415:Biomarkers; D004247:DNA
J Neuropathol Exp Neurol. 2009 Apr;68(4):356-64
19287316
Life Sci. 2007 Apr 3;80(17):1608-18
17343877
Clin Cancer Res. 2002 Jul;8(7):2246-52
12114427
Curr Alzheimer Res. 2009 Jun;6(3):196-204
19519301
Gynecol Oncol. 2009 Jan;112(1):40-6
18851871
Am Fam Physician. 2009 Oct 15;80(8):815-20
19835343
J Mol Diagn. 2009 Jan;11(1):60-65
19074590
Genet Test Mol Biomarkers. 2009 Oct;13(5):623-30
19814617
Semin Cancer Biol. 2009 Jun;19(3):165-71
19429480
Eur J Cancer. 2003 Sep;39(13):1881-7
12932666
Ann N Y Acad Sci. 2006 Sep;1075:235-43
17108217
Expert Rev Mol Diagn. 2009 Apr;9(3):243-57
19379083
Expert Rev Mol Diagn. 2009 Oct;9(7):651-7
19817550
Clin Cancer Res. 2009 Jan 15;15(2):502-10
19147755
PLoS One. 2009 Aug 12;4(8):e6617
19672297
J Urol. 2009 Jul;182(1):324-9
19447423
J Appl Physiol (1985). 2010 Sep;109(3):927-33
20110548
J Clin Oncol. 2008 May 10;26(14):2327-35
18467724
J Neurosci Res. 2007 Jul;85(9):2006-16
17469138
J Cell Biochem. 2009 Sep 1;108(1):3-9
19507229
Clin Cancer Res. 2006 May 1;12(9):2788-94
16675572
Ann Surg Oncol. 2009 May;16(5):1378-83
19224282
Anal Biochem. 1998 Nov 1;264(1):129-32
9784198
Methods Mol Biol. 2009;520:21-38
19381945
Nucleic Acids Res. 2001 Jul 1;29(13):E65-5
11433041
Ann N Y Acad Sci. 2003 Mar;983:243-50
12724229
Semin Reprod Med. 2009 Sep;27(5):417-28
19711252
Lancet Neurol. 2009 Nov;8(11):1056-72
19833297
Nucleic Acids Res. 2000 Apr 15;28(8):E32
10734209
Clin Cancer Res. 2004 Mar 15;10(6):1871-4
15041700
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1827-31
1542678
Am J Gastroenterol. 1990 Apr;85(4):350-5
2183589
Cancer Res. 2006 Jun 15;66(12):6111-7
16778184
Int J Cancer. 2009 Feb 15;124(4):905-10
19035455
J Cancer Res Clin Oncol. 2010 Jun;136(6):847-54
19924441
FEBS Lett. 2009 Jun 5;583(11):1713-20
19376112
J Clin Pathol. 2009 Apr;62(4):308-13
19329710
Endocrinology. 2009 Sep;150(9):4003-11
19574400
Int J Urol. 2009 Jan;16(1):17-22
18721202
Cancer Biol Ther. 2006 Oct;5(10):1369-74
16969071
Br J Cancer. 2006 May 22;94(10):1492-5
16641902
Nucleic Acids Res. 1997 Nov 1;25(21):4422-6
9336479
Biotechniques. 1994 Mar;16(3):416-7
8185912
Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2782-9
19755648
Cancer. 2006 Oct 15;107(8):1859-65
16983705
Oncol Rep. 2007 Aug;18(2):329-36
17611652
Cancer Genet Cytogenet. 2009 Dec;195(2):112-9
19963110
Clin Chim Acta. 2002 Jul;321(1-2):77-87
12031596
Clin Cancer Res. 2009 Jan 1;15(1):315-23
19118060
Biol Chem. 2009 Nov;390(11):1145-53
19747081
Oncogene. 2001 Jun 7;20(26):3348-53
11423985
Cancer. 2010 Apr 1;116(7):1674-80
20143430
FEBS J. 2009 Apr;276(8):2157-64
19250312
Free Radic Biol Med. 2009 May 1;46(9):1241-9
19245828
Anticancer Res. 2007 Mar-Apr;27(2):1207-12
17465264
Br J Cancer. 2009 Jul 7;101(1):124-31
19536096
Ann N Y Acad Sci. 2001 Sep;945:51-8
11708494
Biochem Soc Trans. 2008 Aug;36(Pt 4):575-83
18631120
FEBS Lett. 2007 Mar 6;581(5):795-9
17289032
Cancer Res. 2004 Jul 1;64(13):4442-52
15231653
Methods Mol Biol. 2009;590:165-76
19763503
Brief Funct Genomic Proteomic. 2009 May;8(3):174-83
19535508
Trends Genet. 2009 Jul;25(7):288-97
19540013
Int Rev Neurobiol. 2009;89:67-84
19900616
Clin Neuropharmacol. 2008 Mar-Apr;31(2):104-19
18382183
Cancer Invest. 2009 Oct;27(8):877-84
19548140
Nucleic Acids Res. 1998 May 15;26(10):2255-64
9580672
Arch Pathol Lab Med. 2009 Mar;133(3):454-64
19260750
Rocz Akad Med Bialymst. 2003;48:34-41
14737938
Curr Opin Mol Ther. 2004 Jun;6(3):273-8
15264429
J Urol. 2008 Jan;179(1):346-52
18006010
Clin Chem. 2006 Sep;52(9):1820-4
16840584
Mol Cancer. 2008 Oct 23;7:81
18947422
Clin Cancer Res. 2009 Jun 1;15(11):3881-8
19470736
Cancer Res. 2005 Feb 15;65(4):1141-5
15734995
Expert Rev Neurother. 2009 Jan;9(1):87-98
19102671
Nucleic Acids Res. 2007;35(9):2893-903
17439964
Cancer Res. 2005 May 15;65(10):4101-17
15899800
Clin Cancer Res. 2004 Aug 1;10(15):4933-8
15297393
J Clin Oncol. 2006 Sep 10;24(26):4262-9
16908936
Prostate. 2008 Jan 1;68(1):42-9
18004747
Curr Mol Med. 2009 Apr;9(3):315-23
19355913
PLoS One. 2008 Jul 16;3(7):e2698
18628954